CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.

Difference between revisions of "User:Maria Cleveland"

From CAZypedia
Jump to navigation Jump to search
m (Text replacement - "\^\^\^(.*)\^\^\^" to "$1")
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
[[Image:Maria_2018.jpg|200px|right]]
 
[[Image:Maria_2018.jpg|200px|right]]
Maria Cleveland obtained her B.Sc. in Biology from Queen’s University in Ontario, Canada and completed her PhD in Chemistry under the supervision of Dr. Harry Brumer at the University of British Columbia in the Michael Smith Laboratories. The work focused on recombinant production, biochemical characterization and product analysis of fungal Auxiliary Activity enzymes, specifically [[AA5]]_2 <cite>Cleveland2021a Cleveland2021a</cite>.
+
Maria Cleveland obtained her B.Sc. in Biology in 2014 from Queen’s University in Ontario, Canada. She had worked in the laboratories of Dr. Stan Brown, Dr. Laurent Seroude and Dr. David Zechel studying palladium based metallocycle catalysts, genetics of fruit flies and secondary metabolites of ''Streptomyces curacoi'', respectively. In 2015, she moved to British Columbia where she pursued her PhD in Chemistry under the supervision of Dr. [[User:Harry Brumer|Harry Brumer]] at the University of British Columbia in the Michael Smith Laboratories. The work focused on recombinant production, biochemical characterization and product analysis of fungal Auxiliary Activity enzymes, specifically [[AA5]]_2 <cite>Cleveland2021a Cleveland2021b</cite>. Her work has showcased the wide range of substrate specificities that exist in this subfamily and demonstrated that the catalytic flexibility of the [[AA5]]_2 could be potentially used in a variety of biotech applications.
 
 
----
 
 
 
 
<biblio>
 
<biblio>
 
#Cleveland2021a pmid=34134727
 
#Cleveland2021a pmid=34134727
Line 9: Line 6:
 
#Cleveland2021b pmid=34738149
 
#Cleveland2021b pmid=34738149
  
#Gilbert2008 pmid=18430603
+
 
 
</biblio>
 
</biblio>
  
 
<!-- Do not remove this Category tag -->
 
<!-- Do not remove this Category tag -->
 
[[Category:Contributors|Cleveland,Maria]]
 
[[Category:Contributors|Cleveland,Maria]]

Latest revision as of 14:33, 18 December 2021

Maria 2018.jpg

Maria Cleveland obtained her B.Sc. in Biology in 2014 from Queen’s University in Ontario, Canada. She had worked in the laboratories of Dr. Stan Brown, Dr. Laurent Seroude and Dr. David Zechel studying palladium based metallocycle catalysts, genetics of fruit flies and secondary metabolites of Streptomyces curacoi, respectively. In 2015, she moved to British Columbia where she pursued her PhD in Chemistry under the supervision of Dr. Harry Brumer at the University of British Columbia in the Michael Smith Laboratories. The work focused on recombinant production, biochemical characterization and product analysis of fungal Auxiliary Activity enzymes, specifically AA5_2 [1, 2]. Her work has showcased the wide range of substrate specificities that exist in this subfamily and demonstrated that the catalytic flexibility of the AA5_2 could be potentially used in a variety of biotech applications.

  1. Cleveland M, Lafond M, Xia FR, Chung R, Mulyk P, Hein JE, and Brumer H. (2021). Two Fusarium copper radical oxidases with high activity on aryl alcohols. Biotechnol Biofuels. 2021;14(1):138. DOI:10.1186/s13068-021-01984-0 | PubMed ID:34134727 [Cleveland2021a]
  2. Cleveland ME, Mathieu Y, Ribeaucourt D, Haon M, Mulyk P, Hein JE, Lafond M, Berrin JG, and Brumer H. (2021). A survey of substrate specificity among Auxiliary Activity Family 5 copper radical oxidases. Cell Mol Life Sci. 2021;78(24):8187-8208. DOI:10.1007/s00018-021-03981-w | PubMed ID:34738149 [Cleveland2021b]

All Medline abstracts: PubMed